Can myocardial susceptibility quantification be an imaging biomarker for cardiac amyloidosis?

PURPOSE: This study aimed to evaluate whether quantification of myocardial susceptibility by cardiac magnetic resonance imaging (CMR) can be an imaging biomarker for cardiac amyloidosis (CA). MATERIALS AND METHODS: Twenty-six patients with CA underwent CMR, including magnetic phase imaging with a 3....

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Hidetaka, Oda, Seitaro, Kidoh, Masafumi, Nakaura, Takeshi, Morita, Kosuke, Nagayama, Yasunori, Yoneda, Tetsuya, Takashio, Seiji, Misumi, Yohei, Ueda, Mitsuharu, Tsujita, Kenichi, Hirai, Toshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068634/
https://www.ncbi.nlm.nih.gov/pubmed/34841460
http://dx.doi.org/10.1007/s11604-021-01228-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068634/
https://www.ncbi.nlm.nih.gov/pubmed/34841460
http://dx.doi.org/10.1007/s11604-021-01228-z

Ejemplares similares